JUBLPHARMA / NSE / Biotechnology & Drugs
Jubilant Pharmova
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High1,250
Target Low783.75
Target Mean2.25
Target Median56.25
Risk Metrics
Overall RiskBalanced risk
Board Risk29.82
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Tax Setback for Jubilant Generics as Department Orders Rs 107.89 Cr Adjustment Medical Dialogues
Ashish Mukkirwar appointed CFO of Jubilant Pharmova Indian Pharma Post
Jubilant Pharmova re-appoints MDs for three years scanx.trade
Jubilant Pharmova Ltd is Rated Sell Markets Mojo
Jubilant Pharmo Consolidated March 2026 Net Sales at Rs 2,290.00 crore, up 18.73% Y-o-Y Moneycontrol.com
Jubilant Pharmo Standalone March 2026 Net Sales at Rs 70.30 crore, down 67.65% Y-o-Y Moneycontrol.com
Ashish Mukkirwar Appointed as Chief Financial Officer at Jubilant Pharmova Limited hrtoday.in
Jubilant Pharmova FY26 revenue rises 14%; PAT grows 7% scanx.trade
Stock FAQs
What is the symbol and ISIN of Jubilant Pharmova?
Jubilant Pharmova has the symbol JUBLPHARMA and ISIN - INE700A01033.
What is the current price of Jubilant Pharmova?
Jubilant Pharmova is currently trading at INR 1,019.35.
What are the year high and year low of Jubilant Pharmova?
Jubilant Pharmova has a year high of INR 1,250.00 and a year low of INR 783.75.
What is the market capitalization of Jubilant Pharmova?
Jubilant Pharmova has a market capitalization of INR 16,227.90 crore.
What is the P/E ratio of Jubilant Pharmova?
Jubilant Pharmova has a P/E ratio of 32.46.
What is the dividend yield of Jubilant Pharmova?
Jubilant Pharmova has a dividend yield of 0.49%.
How is the financial performance of Jubilant Pharmova based on revenue, net income, and EPS?
Jubilant Pharmova has revenue of INR 82,796.00 crore, net income of INR 3,985.00 crore, and EPS of INR 27.39.
What is the book value of Jubilant Pharmova?
Jubilant Pharmova has a book value of INR 188.78.
What is the debt-to-equity ratio of Jubilant Pharmova?
Jubilant Pharmova has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Jubilant Pharmova?
Jubilant Pharmova has a price-to-book ratio of 5.40 and a price-to-sales ratio of 0.20.
© SharekeyX | Rusaka Technologies 2024-2026